Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Ping An Leads $15 Million Round in Riverain, a US Imaging Software Company

publication date: Sep 18, 2019

China's Ping An Insurance Company led a $15 Million investment in Riverain Technologies, an Ohio company that develops AI imaging software. Riverain's suite of patented ClearRead(TM) software tools are designed to improve a clinician's ability to detect cancer and other cell anomalies in thoracic CT and X-ray images. The software, which is already available in the US, is especially aimed at early detection of lung cancer. The investment will be used to bring ClearRead(TM) to global markets. Ping An's Global Voyager Fund made the investment. More details....

Stock Symbols: (HK: 2318; SHA: 601318)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.